Is neonatal antiretroviral therapy a risk factor for NEC occurrence?

Maria Pia De Carolis, Serafina Lacerenza, Daniele De Luca, Iliana Bersani, Simonetta Costa, Costantino Romagnoli

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

An association between maternal human immunodeficiency virus (HIV) infection and increased necrotizing enterocolitis (NEC) risk has been reported. Viral exposure and maternal antiretroviral therapy have been described as mediators of this risk. We report a preterm patient with delayed meconium passage and subsequent NEC, in which both the above-mentioned mechanisms were excluded, suggesting that neonatal antiretroviral therapy could be the most relevant risk factor for NEC in a susceptible preterm gut.
Lingua originaleEnglish
pagine (da-a)108-110
Numero di pagine3
RivistaTurkish Journal of Pediatrics
Volume2010
Stato di pubblicazionePubblicato - 2010

Keywords

  • NEC
  • antiretroviral therapy

Fingerprint Entra nei temi di ricerca di 'Is neonatal antiretroviral therapy a risk factor for NEC occurrence?'. Insieme formano una fingerprint unica.

Cita questo